Search
Returning search results with filters:
Remove filter for
Issue: Product safety
Remove filter for
Last updated: 2023
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2023
- December 20232 results available
- November 20236 results available
- October 20233 results available
- August 20233 results available
- July 20233 results available
- May 20232 results available
- April 20233 results available
- March 20232 results available
- February 20234 results available
- January 20232 results available
Recall class
Displaying 16 - 30 of 30 items.
Unauthorized health products seized from two Facebook Marketplace sellers, Pinas-Sabay Canada and Y&Y Online Retail
AlertPublic advisory | 2023-07-18
Rhinaris Nasal Mist: One lot recalled due to risk of microbial growth which may lead to infection
AlertPublic advisory | 2023-07-07
Unauthorized drugs for abortion and emergency contraception sold illegally on “Dr. Pooja” websites
AlertPublic advisory | 2023-05-16
Limitations of test strips to check illegal drugs for dangerous substances
AlertPublic advisory | 2023-04-17
Robikids and Solmux are unauthorized children’s syrups for thinning mucus and may pose serious health risks
AlertPublic advisory | 2023-03-16
Unauthorized health products from Kausch International Goods may pose serious health risks
AlertPublic advisory | 2023-03-01
Unauthorized prescription drug called Solmux removed from sale from Palengke Pinoy store in Camrose, AB, and Facebook store
AlertPublic advisory | 2023-02-17
Amitriptyline antidepressant drugs recalled because of a nitrosamine impurity
AlertPublic advisory | 2023-02-07
APO-AMITRIPTYLINE 10mg: NDMA Impurity
RecallHealth product recall | 2023-02-07
Know the risks: Replacing a healthy natural eye lens with an intraocular eye lens for vision correction
AlertPublic advisory | 2023-02-03
Unauthorized health products removed from sale from More to Shoppe Facebook store and its Edson, Alberta, warehouse
AlertPublic advisory | 2023-01-20
EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance to specific SARS-CoV-2 Subvariants
AlertHealth professional risk communication | 2023-01-17